Adjuvant Hypo Fractionated Whole Breast Radiation therapy A Review of Literature from Bench to Clinic

Tareq Salah
Additional contact information
Tareq Salah: Clinical oncology and nuclear medicine Department, Faculty of medicine, Assiut university, Egypt

Cancer Therapy & Oncology International Journal, 2020, vol. 16, issue 2, 34-41

Abstract: Adjuvant Radiotherapy (RT) is an essential part of Breast cancer treatment with proved survival advantage . Although its radiobiological and clinical advantage becoming a standard of care practice in most centers, Hypofractionation (HF) still of a concern in certain clinical situations. Treatment Protocols are still variable across the ocean and worldwide. With the recent publications of the extreme hypofractionation we have a wide range of evidence-based protocols. This is a review of radiobiological bases and current evidence for hypofractionation in breast cancer radiation therapy starting from the basic science base up to the most recent studies.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555934.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555934.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:16:y:2020:i:2:p:34-41

DOI: 10.19080/CTOIJ.2020.16.555934

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().